Skip to main content
. 2016 Apr 28;11(4):e0153765. doi: 10.1371/journal.pone.0153765

Fig 3. Prediction of ICU mortality by TWEAK serum concentrations.

Fig 3

(a) Patients that succumbed to death during ICU treatment displayed higher TWEAK serum levels compared to survivors. (b) Kaplan-Meier survival curves of ICU patients showed that patients with low TWEAK levels an increased short-term survival at the ICU. (c) Kaplan-Meier survival curves of ICU patients revealed that patients with TWEAK levels < 209 ng/ml had an increased ICU survival. (d) ROC curve analyses comparing the prognostic value of TWEAK at admission for ICU survival with the patients´ age and routinely used laboratory parameters.